Amicar 1000mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To maintain the medication's effectiveness, store it at room temperature and avoid freezing.
If you miss a dose, contact your doctor for guidance on the best course of action to take.
Lifestyle & Tips
- Take exactly as prescribed by your doctor. Do not stop taking it without consulting your doctor.
- Report any unusual bleeding or bruising, or signs of new blood clots (like pain/swelling in legs, chest pain, shortness of breath) immediately.
- Report any muscle pain, weakness, or dark urine, as these could be signs of a serious muscle problem.
- Avoid activities that could lead to injury or bleeding while on this medication, especially if you have an underlying bleeding disorder.
Available Forms & Alternatives
Available Strengths:
Generic Alternatives:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Abnormal heartbeat or slow heartbeat
Unexplained bruising or bleeding
Swelling
Seizures
Severe dizziness or fainting
Hallucinations (seeing or hearing things that are not there)
Confusion
Weakness on one side of the body, trouble speaking or thinking, balance changes, drooping on one side of the face, or blurred vision
Fever, chills, or sore throat
Changes in vision
Ringing in the ears
Signs of a blood clot, such as:
+ Chest pain or pressure
+ Coughing up blood
+ Shortness of breath
+ Swelling, warmth, numbness, color changes, or pain in a leg or arm
+ Trouble speaking or swallowing
Additionally, this medication can cause severe muscle problems, which may lead to kidney issues. Inform your doctor if you experience:
Muscle pain or weakness, especially if accompanied by fatigue, weakness, or fever
Difficulty urinating or changes in urine output
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor:
Headache
Upset stomach or vomiting
Stomach pain or diarrhea
Dizziness, fatigue, or weakness
Nasal congestion
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe muscle pain or weakness
- Dark or reddish-brown urine
- Swelling, pain, or tenderness in a leg (signs of DVT)
- Sudden shortness of breath or chest pain (signs of PE)
- Sudden numbness or weakness, especially on one side of the body
- Severe headache, confusion, or problems with vision or speech
- Unusual bleeding or bruising that is worse than expected
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you have a history of blood clots.
If you are taking any medications that may increase the risk of blood clots, including:
+ Factor IX complex
+ Anti-inhibitor coagulant complex
+ Hormone-based birth control methods
+ Other medications that may have this effect (consult your doctor or pharmacist if you are unsure)
Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to:
Inform your doctor and pharmacist about all medications you are taking, including:
+ Prescription and over-the-counter (OTC) medications
+ Natural products
+ Vitamins
Share information about your health problems.
Verify that it is safe to take this medication with all your other medications and health conditions.
* Do not start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Nausea
- Diarrhea
- Dizziness
- Hypotension (low blood pressure)
- Bradycardia (slow heart rate)
- Acute renal failure
- Thrombosis (blood clot formation)
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive and symptomatic. Hemodialysis may be effective in removing the drug.
Drug Interactions
Major Interactions
- Factor IX Complex Concentrates (e.g., Konyne 80, Profilnine SD)
- Anti-inhibitor Coagulant Complex (e.g., FEIBA NF)
- Estrogens (e.g., oral contraceptives, hormone replacement therapy)
- Thrombolytic agents (e.g., alteplase, streptokinase, urokinase)
Moderate Interactions
- Chlorpromazine (may increase risk of myopathy)
- Corticosteroids (may increase risk of myopathy)
Monitoring
Baseline Monitoring
Rationale: Aminocaproic acid is primarily renally excreted; impaired renal function requires dose adjustment.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline hematologic status and identify underlying causes of bleeding.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline coagulation status and guide therapy.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Daily or every 2-3 days, especially in patients with impaired renal function or prolonged therapy.
Target: Within normal limits or stable for patient's baseline.
Action Threshold: Significant increase in BUN/creatinine; consider dose adjustment or discontinuation.
Frequency: Daily or as clinically indicated, especially during acute bleeding episodes.
Target: Dependent on clinical goal (e.g., normalization of bleeding, prevention of re-bleeding).
Action Threshold: Persistent bleeding despite therapy, or signs of hypercoagulability.
Frequency: Continuously
Target: Absence of thrombotic events.
Action Threshold: New onset of pain, swelling, redness in limbs; shortness of breath, chest pain; neurological deficits. Discontinue drug and initiate appropriate treatment.
Frequency: Daily
Target: Absence of muscle symptoms.
Action Threshold: New onset of muscle pain, weakness, or dark urine. Discontinue drug and check CK levels.
Symptom Monitoring
- Bleeding (cessation or reduction)
- Signs of thrombosis (e.g., leg pain/swelling, chest pain, shortness of breath, sudden vision changes, slurred speech)
- Muscle pain or weakness
- Dark or reddish-brown urine (rhabdomyolysis)
- Nausea, vomiting, diarrhea
- Dizziness, headache
Special Patient Groups
Pregnancy
Use only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown some evidence of teratogenicity at high doses.
Trimester-Specific Risks:
Lactation
Aminocaproic acid is excreted in breast milk. Caution should be exercised when administered to a nursing mother. Consider potential risks to the infant versus benefits to the mother.
Pediatric Use
Safety and efficacy have not been fully established in pediatric patients. Use with caution and generally only when the potential benefits outweigh the risks. Dosing is often weight or body surface area-based, and close monitoring is required.
Geriatric Use
Use with caution in elderly patients, as they are more likely to have decreased renal function. Dose adjustment may be necessary based on renal creatinine clearance. Monitor closely for adverse effects, particularly thrombotic events.
Clinical Information
Clinical Pearls
- Aminocaproic acid should be administered promptly after the onset of bleeding or prior to procedures where excessive bleeding is anticipated due to fibrinolysis.
- Rapid IV infusion can cause hypotension, bradycardia, and arrhythmias; administer IV doses slowly (e.g., over 1 hour for initial dose).
- Monitor for signs of thrombosis (e.g., DVT, PE, arterial thrombosis) throughout therapy, especially in patients with pre-existing thrombotic risk factors.
- Patients should be advised to report any muscle pain, weakness, or dark urine immediately, as these may indicate myopathy or rhabdomyolysis.
- Not effective for bleeding due to thrombocytopenia or other coagulation factor deficiencies unless accompanied by hyperfibrinolysis.
- Consider tranexamic acid as an alternative, which may have a more favorable pharmacokinetic profile and potentially fewer side effects in some cases.
Alternative Therapies
- Tranexamic acid (another antifibrinolytic agent)